Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fimmu.2017.00304 http://scihub22266oqcxt.onion/10.3389/fimmu.2017.00304 C5374157!5374157!28408907     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Immunol 2017 ; 8 (ä): ä Nephropedia Template TP {{tp|p=28408907|t=2017. Type I Interferons and Natural Killer Cell Regulation in Cancer |pdf=|usr=}}{{28408907}} gab.com Text Type I Interferons and Natural Killer Cell Regulation in Cancer JO: Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=28408907 #FOAvip Type I interferons (IFNs) are known to mediate antitumor effects against several tumor types and have therefore been commonly used in clinical anticancer treatment. However, how IFN signaling exerts its beneficial effects is only partially understood. The clinically relevant activity of type I IFNs has been mainly attributed to their role in tumor immune surveillance. Different mechanisms have been postulated to explain how type I IFNs stimulate the immune system. On the one hand, they modulate innate immune cell subsets such as natural killer (NK) cells. On the other hand, type I IFNs also influence adaptive immune responses. Here, we review evidence for the impact of type I IFNs on immune surveillance against cancer and highlight the role of NK cells therein. Twit Text FOAVip Type I Interferons and Natural Killer Cell Regulation in Cancer ????Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=28408907 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28408907 #FOAvip English Wikipedia <ref>{{Cite pmid|28408907}}</ref> Type I Interferons and Natural Killer Cell Regulation in Cancer #MMPMID28408907 Müller L; Aigner P; Stoiber D Front Immunol 2017[]; 8 (ä): ä PMID28408907show ga Type I interferons (IFNs) are known to mediate antitumor effects against several tumor types and have therefore been commonly used in clinical anticancer treatment. However, how IFN signaling exerts its beneficial effects is only partially understood. The clinically relevant activity of type I IFNs has been mainly attributed to their role in tumor immune surveillance. Different mechanisms have been postulated to explain how type I IFNs stimulate the immune system. On the one hand, they modulate innate immune cell subsets such as natural killer (NK) cells. On the other hand, type I IFNs also influence adaptive immune responses. Here, we review evidence for the impact of type I IFNs on immune surveillance against cancer and highlight the role of NK cells therein. äType I Interferons and Natural Killer Cell Regulation in Cancer (epmc).pdf DeepDyve Pubget Overpricing